STOCK TITAN

Rezolve Ai Slams Commerce.com Board’s "Desperate" Poison Pill That Will Dilute Shareholders and Stagnate Growth Further

(Moderate)
(Neutral)
Tags
AI

Rezolve Ai (NASDAQ: RZLV) criticized Commerce.com (NASDAQ: CMRC) for adopting a stockholder rights plan it calls a “poison pill,” saying the board is entrenching itself ahead of the May 14, 2026 director election.

Rezolve Ai cited Commerce.com’s $2.50 share price, a 96% decline from its post‑IPO peak, a Wall Street target of $11.00, contracted 2026 revenue of $232M, and full‑year guidance of $360M.

Loading...
Loading translation...

Positive

  • Contracted 2026 revenue of $232 million
  • Full‑year guidance of $360 million (7.5x year‑on‑year growth)
  • Analyst consensus price target of $11.00 implies material upside

Negative

  • Commerce.com stock down 96% from post‑IPO peak
  • Current Commerce.com trading price of $2.50
  • Board adopted a rights plan within one week of Rezolve Ai's proposal

News Market Reaction – RZLV

+1.97%
21 alerts
+1.97% Session close to close
+7.2% Peak in 24 hr 21 min
$955.17M Market Cap
0.2x Rel. Volume

In the Apr 14 session, RZLV gained 1.97%, reflecting a mild positive market reaction. Argus tracked a peak move of +7.2% during that session. Our momentum scanner triggered 21 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement intensifies Rezolve Ai’s campaign against Commerce.com’s newly adopted poison pill...
Analysis

This announcement intensifies Rezolve Ai’s campaign against Commerce.com’s newly adopted poison pill, highlighting Rezolve’s $232 million in contracted 2026 revenue and $360 million guidance to argue for a combination. Recent AI launches, rapid growth, and ongoing SEC shelf and resale activity frame a story of aggressive expansion funded by capital markets. Investors may monitor future Commerce.com board actions, legal developments around the rights plan, and Rezolve’s ability to sustain growth while managing dilution and balance sheet risk.

Key Figures

Analyst target price: $11.00 Contracted 2026 revenue: $232 million 2026 revenue guidance: $360 million +5 more
8 metrics
Analyst target price $11.00 Rezolve Ai Wall Street consensus target cited versus current valuation debate
Contracted 2026 revenue $232 million Rezolve Ai contracted revenue base used to counter ‘47% discount’ claim
2026 revenue guidance $360 million Full-year guidance highlighted as part of Rezolve Ai growth argument
Year-on-year growth 7.5 times Rezolve Ai stated year-on-year growth rate embedded in 2026 guidance
Commerce.com stock decline 96% Drop from post-IPO peak cited to criticize Commerce.com board performance
Commerce.com share price $2.50 Current price at which Commerce.com shareholders are described as ‘stuck’
Merchant count more than 60,000 Number of merchants on Commerce.com platform referenced in combination rationale
Commerce.com growth forecast 1.5% Board’s low growth forecast contrasted with Rezolve Ai’s proposed upside

Previous AI Reports

4 past events · Latest: Apr 13 (Positive)
Same Type Pattern 4 events
Date Event Sentiment 24h Move Catalyst
Apr 13 AI product launch Positive +6.7% Launched brainpowa™ commerce-tuned AI models on Microsoft Foundry with Azure focus.
Apr 09 M&A campaign update Positive -9.9% Rebutted Commerce.com board, highlighting Rezolve’s growth vs. Commerce.com’s weak outlook.
Apr 08 M&A proposal Positive -2.1% Outlined proposal to create a $700M+ agentic commerce platform targeting Commerce.com holders.
Mar 20 Conference appearance Neutral -1.6% Announced Roth Conference fireside chat with Microsoft on agentic commerce.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

AI-tagged news has produced mixed reactions: strong gains on product and guidance updates, but negative moves around the Commerce.com campaign, with an average move of -0.28%.

Recent Company History

Over recent weeks, Rezolve Ai has issued several AI-focused updates, including a 543% H2 revenue surge and 2026 guidance of $360M, plus the launch of its brainpowa™ models on Microsoft Foundry. In parallel, the company has pursued a contested combination with Commerce.com, taking its case directly to Commerce.com shareholders. Today’s criticism of Commerce.com’s poison pill fits into this ongoing campaign narrative following prior offer-related releases.

Key Terms

stockholder rights plan, poison pill, rights plan, exchange offer, +2 more
6 terms
stockholder rights plan regulatory
"responded to the Commerce.com, Inc. Board of Directors’ adoption of a stockholder rights plan"
A stockholder rights plan is a strategy used by a company to protect itself from unwanted takeovers by making it more difficult or expensive for an outside party to acquire a large ownership stake without approval. It often involves granting existing shareholders special rights that activate if someone attempts to buy a significant portion of the company, helping to safeguard the company's interests and giving investors confidence that decisions are made with stability in mind.
poison pill financial
"adoption of a stockholder rights plan (“Poison Pill” or “Rights Plan”)"
A poison pill is a defensive tactic a company’s board adopts to make an unwanted takeover much more costly or difficult, typically by allowing existing shareholders (but not the bidder) to buy additional shares or triggering dilution once a single buyer crosses a ownership threshold. For investors, it matters because it can protect a company’s long‑term plans and raise the price a bidder must pay, but it can also block or delay takeovers that might deliver a premium to shareholders.
rights plan regulatory
"Rezolve Ai is assessing whether the Rights Plan complies with applicable law"
A rights plan is a board-authorized mechanism that gives existing shareholders the right to buy additional shares at a discount if a single investor accumulates a large stake, making an unwanted takeover much more costly and diluting the buyer’s control. It matters to investors because it can protect a company’s long-term strategy from hostile bids but also can reduce the chance of a takeover premium or dilute share value, so shareholders should assess whether the plan serves their interests—think of it as a rule that makes a sudden purchase of a house much harder and more expensive for an aggressive buyer.
exchange offer financial
"seeking to prevent shareholders from considering a value-maximizing exchange offer"
An exchange offer is a proposal where a company asks investors to swap existing securities, like bonds or shares, for new ones, often with different terms or maturity dates. It matters to investors because it can affect the value of their holdings and the company's financial strategy, potentially providing benefits like better interest rates or reduced debt.
fiduciary duties regulatory
"whether the Board’s adoption of the Rights Plan is consistent with its fiduciary duties"
Fiduciary duties are the legal and ethical responsibilities that company directors, officers, or financial advisors have to put shareholders’ interests ahead of their own, acting with honesty, care, and loyalty. Think of it like a guardian managing someone’s money: choices must prioritize the owner’s benefit, avoid conflicts, and be made with prudent judgment; investors rely on these duties to ensure decisions aren’t self‑serving and to provide grounds for legal action if abused.
form 8-k regulatory
"once it has had an opportunity to review Commerce.com’s Form 8-K filing"
A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Labels Tactic a "White Flag" Following Prolonged Equity Collapse and No Clear Recovery Plan

Calls Into Question Board’s Competence Ahead of May 14 Election

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai PLC (NASDAQ: RZLV), a global leader in AI-powered commerce, today responded to the Commerce.com, Inc. (Nasdaq: CMRC) Board of Directors’ adoption of a stockholder rights plan (“Poison Pill” or “Rights Plan”).

Rezolve Ai views this as a transparent attempt by a failing Board to entrench itself and prevent Commerce.com shareholders from acting on an offer that presents material upside. Commerce.com's claim of a 47% discount is based on a single day's closing price. It ignores Rezolve Ai's Wall Street analyst consensus target of $11.00, the company's contracted 2026 revenue of $232 million, full-year guidance of $360 million representing 7.5 times year-on-year growth, and the materially higher trading multiple a combined platform of this scale and trajectory would command. Valuing a transformational combination by a historic spot price is misleading and obscures the opportunity from the very shareholders Commerce.com's Board claims to be protecting.

The Commerce.com Board has presided over a 96% decline in the company's stock price from its post-IPO peak. Their shareholders are now stuck in an illiquid position, with limited ability to exit at the current $2.50 share price. The Board is now seeking to prevent shareholders from considering a value-maximizing exchange offer by threatening to impose massive dilution on any potential acquiror. Through the adoption of the Poison Pill, the Commerce.com Board is effectively forcing shareholders to remain under the stewardship of the directors responsible for the tremendous erosion in shareholder value.

With the election of directors scheduled to occur on May 14, 2026 at Commerce.com’s 2026 annual meeting, Rezolve Ai believes shareholders will soon have an opportunity to express their views on the Board’s failure of leadership and vision and the need for transformational change.

“One week after Rezolve Ai took its case directly to Commerce.com's shareholders, their Board's response was not engagement, not dialogue, not a counter-proposal - it was the adoption of a poison pill,” said Daniel M Wagner, CEO of Rezolve Ai. “A Board forecasting growth of 1.5% has chosen to try to lock its shareholders out of a proposal that implies more than double the current share price, rather than let them decide for themselves. The Commerce.com Board has poisoned its own well.”

Commerce.com's more than 60,000 merchants are equally affected. They are operating on a platform falling further behind every quarter with no credible path to AI-native infrastructure under current management. They too deserve a clear path to commercially viable enterprise AI. Together, Rezolve Ai and Commerce.com would form an integrated, full-stack smart commerce platform, combining Rezolve's AI-native infrastructure with Commerce.com's network of thousands of mid-market and enterprise merchants to create a single, end-to-end engine for the agentic commerce era.

“Rezolve Ai's Brain Suite would give those merchants conversational commerce capability, AI-native infrastructure, and a proprietary payment rail that Commerce.com’s current platform cannot deliver,” Wagner continued. “Commerce.com has chosen entrenchment over transformation, a decision that serves neither its shareholders nor the merchants whose businesses depend on its platform. Let me be equally clear about the underlying reality: Rezolve does not need Commerce.com to execute its strategy. With or without Commerce.com, Rezolve Ai is scaling rapidly and extending its leadership in AI-driven commerce. Commerce.com shareholders deserve the opportunity to evaluate the attractiveness of our proposed combination. Tomorrow morning, at 0800 ET, I will be speaking directly to the people who actually own this company - because a poison pill is not a strategy, and this board knows it.”

Rezolve Ai is assessing whether the Rights Plan complies with applicable law and whether the Board’s adoption of the Rights Plan is consistent with its fiduciary duties to shareholders. A Rights Plan implemented within one week of shareholders being apprised of a forthcoming proposal implying more than double the current market price, by a board that has overseen near-total destruction of shareholder value, raises serious questions. Rezolve Ai will provide a further update in due course once it has had an opportunity to review Commerce.com’s Form 8-K filing with the details of the Rights Plan.

Investor Call: Wednesday, April 15, 2026, at 0800 Eastern Time
Rezolve Ai will host an investor call open to shareholders of both companies tomorrow, Wednesday, April 15, 2026, at 0800 Eastern Time. Dial-in details and webcast registration are available at investor.rezolve.com.

Webcast link: https://edge.media-server.com/mmc/p/eo6ii4pv

Additional Information
For more information, shareholders can contact Rezolve Ai's Information Agent, Georgeson LLC.

Information Agent: Bill Fiske / Jim Gill, Georgeson LLC. Toll-free: +1 (877) 811-6561. Email: CommerceInfo@Georgeson.com.

Shareholders are encouraged to review the formal Open Letter and Rezolve Ai's 2025 Annual Report, both filed with the SEC and available at investor.rezolve.com.

Media Contact
The One Nine Three Group
RezolveAi@the193.com

Investor Contact
investors@rezolve.com

About Rezolve Ai
Rezolve Ai (NASDAQ: RZLV) is a global leader in AI-native commerce infrastructure. Its proprietary Brain Suite platform delivers intelligent, end-to-end agentic commerce, unifying discovery, transaction, and fulfilment across enterprise retail at global scale. Rezolve Ai entered 2026 with $232 million in contracted revenue, full-year guidance of $360 million representing 7.5 times year-on-year growth, and $750 million in total funding secured. For more information, visit rezolve.com.

Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. The actual results of Rezolve AI plc ("Rezolve") may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect", "estimate", "project", "budget", "forecast", "anticipate", "intend", "plan", "may", "will", "could", "should", "believes", "predicts", "potential", "continue", "design" and similar expressions as they relate to us, our performance and/or our technology, including statements regarding the proposed transaction, benefits and synergies of the proposed transaction and future opportunities for the combined company, are intended to identify such forward-looking statements. These statements reflect management's current beliefs, assumptions and expectations and are subject to a number of factors that may cause actual results to differ materially. Such factors include but are not limited to the ultimate outcome of any possible transaction between Rezolve and Commerce.com Inc. ("Commerce"), including the possibility that the terms of any definitive agreement will be materially different from those described herein; uncertainties as to whether Commerce will cooperate with Rezolve regarding the proposed transaction; Rezolve's ability to consummate the proposed transaction with Commerce; the conditions to the completion of the proposed transaction, including the receipt of any required shareholder approvals and any required regulatory approvals; the possibility that Rezolve may be unable to achieve expected synergies and operating efficiencies within the expected time-frames or at all and to successfully integrate Commerce's operations with those of Rezolve; that such integration may be more difficult, time-consuming or costly than expected; and that operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers or suppliers) may be greater than expected following the proposed transaction or the public announcement of the proposed transaction. You should also carefully consider the risks and uncertainties described in the "Risk Factors" section of Rezolve's Annual Report on Form 20-F for the fiscal year ended December 31, 2025, as filed with the SEC on March 30, 2026 (the "Rezolve 20-F"), and its subsequent filings made with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Most of these factors are outside Rezolve's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) competition, the ability of Rezolve to grow and manage growth profitably, and retain its management and key employees; (2) changes in applicable laws or regulations; and (3) weakness in the economy, market trends, uncertainty and other conditions in the markets in which Rezolve operates, and other factors beyond its control, such as inflation or rising interest rates. Rezolve cautions that the foregoing list of factors is not exclusive and not to place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. Except as required by applicable law, Rezolve does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances, or otherwise.

Additional Information Regarding the Proposed Transaction
This press release does not constitute an offer to buy or sell, or the solicitation of an offer to buy or sell, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended. This press release relates to a proposal that Rezolve has made for a business combination transaction with Commerce. In furtherance of this proposal and subject to future developments, Rezolve (and, if applicable, Commerce) may file one or more registration statements, proxy statements, tender offer statements or other documents with the Securities and Exchange Commission (the "SEC").

Investors and security holders of Rezolve and Commerce are urged to read the proxy statement(s), registration statement, tender offer statement, prospectus and/or other documents filed with the SEC carefully in their entirety if and when they become available as they will contain important information about the proposed transaction. Any definitive proxy statement(s) or prospectus(es) (if and when available) will be mailed to shareholders of Rezolve and/or Commerce, as applicable. Investors and security holders will be able to obtain free copies of these documents (if and when available) and other documents filed with the SEC by Rezolve through the web site maintained by the SEC at www.sec.gov, and by visiting Rezolve's investor relations site at investor.rezolve.com.

This press release is neither a solicitation of a proxy nor a substitute for any proxy statement, registration statement, tender offer statement, prospectus or other document Rezolve and/or Commerce may file with the SEC in connection with the proposed transaction. Nonetheless, Rezolve and its directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transactions. You can find information about Rezolve's executive officers and directors in the Rezolve 20-F. Additional information regarding the interests of such potential participants will be included in one or more registration statements, proxy statements, tender offer statements or other documents filed with the SEC if and when they become available. These documents (if and when available) may be obtained free of charge from the SEC's website www.sec.gov, and by visiting Rezolve's investor relations site at investor.rezolve.com.


FAQ

What did Rezolve Ai (RZLV) announce about Commerce.com’s (CMRC) rights plan on April 21, 2026?

Rezolve Ai sharply criticized Commerce.com’s adoption of a rights plan, calling it an entrenchment move by the board. According to Rezolve Ai, the rights plan blocks shareholders from considering an exchange offer and was adopted within one week of Rezolve Ai’s proposal.

How does Rezolve Ai say the proposed combination would affect Commerce.com (CMRC) shareholders?

Rezolve Ai says the combination would offer material upside beyond current trading levels. According to Rezolve Ai, analyst consensus target is $11.00 and contracted 2026 revenue is $232 million, indicating a higher valuation for a combined platform.

What financial figures did Rezolve Ai cite to support its proposal for Commerce.com (CMRC)?

Rezolve Ai cited contracted 2026 revenue of $232 million and full‑year guidance of $360 million. According to Rezolve Ai, the $360 million guidance represents approximately 7.5 times year‑on‑year growth for Commerce.com in 2026.

What immediate actions did Rezolve Ai announce for investors after the rights plan adoption?

Rezolve Ai said it is reviewing legal compliance of the rights plan and will update investors after reviewing Commerce.com’s Form 8‑K. According to Rezolve Ai, it will also host an investor call on April 15, 2026 at 0800 ET to address shareholders.

How did Rezolve Ai describe Commerce.com’s board performance and stock performance?

Rezolve Ai described the board as responsible for a 96% decline from post‑IPO peak and limited shareholder exit options. According to Rezolve Ai, this decline left Commerce.com trading at about $2.50 per share and illiquid for many holders.

When is Commerce.com’s director election and how is it relevant to Rezolve Ai’s campaign?

The director election is scheduled for May 14, 2026, and Rezolve Ai views it as an opportunity for shareholders to respond to board actions. According to Rezolve Ai, the election timing is central after the board adopted the rights plan.